Skip to content

Drug interactions

Bosutinib + Mitomycin

Severity: Moderate

Bosutinib and Mitomycin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Bosutinib can inhibit P-glycoprotein, which may increase exposure to P-gp substrates. Bosutinib also causes myelosuppression, so overlapping marrow toxicity with mitomycin is a more relevant concern than the transporter effect.

What this interaction means in plain words

Bosutinib and Mitomycin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bosutinib belongs to Oncology; Mitomycin belongs to Oncology.

Evidence level: Low

Why it happens

Additive myelosuppression, plus possible P-gp inhibition by bosutinib raising mitomycin exposure.

What to do

Monitor complete blood counts closely and adjust or hold either drug if significant cytopenias occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosutinib and Mitomycin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosutinib with Mitomycin?

MediHelp rates the interaction as moderate. Bosutinib and Mitomycin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Bosutinib can inhibit P-glycoprotein, which may increase exposure to P-gp substrates. Bosutinib also causes myelosuppression, so overlapping marrow toxicity with mitomycin is a more relevant concern than the transporter effect.

How serious is the interaction between Bosutinib and Mitomycin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts closely and adjust or hold either drug if significant cytopenias occur.

What other medicines interact with Mitomycin?

MediHelp also lists interactions of Mitomycin with, for example, Bacitracin, Deferiprone, Dengue vaccine. The full list is on the Mitomycin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in